Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Karolinska Development Ab (0P3C)

Karolinska Development Ab
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0P3C
DateTimeSourceHeadlineSymbolCompany
16/05/202415:40UK RegulatoryKarolinska Development’s Annual General Meeting 2024LSE:0P3CKarolinska Development Ab
08/05/202408:30UK RegulatoryKarolinska Development’s portfolio company Umecrine Cognition initiates second part of clinical phase 1a/2 study in PBCLSE:0P3CKarolinska Development Ab
26/04/202407:00UK RegulatoryInterim Report - January-March 2024LSE:0P3CKarolinska Development Ab
16/04/202407:00UK RegulatoryNotice of Annual General Meeting in Karolinska Development AB (publ)LSE:0P3CKarolinska Development Ab
22/03/202408:30UK RegulatoryKarolinska Development’s portfolio company Umecrine Cognition presents positive safety data from the first part of its Phase 1b/2 study in PBCLSE:0P3CKarolinska Development Ab
22/03/202407:00UK RegulatoryKarolinska Development Annual Report 2023 publishedLSE:0P3CKarolinska Development Ab
14/03/202411:48UK RegulatoryKarolinska Development’s portfolio company Aprea Therapeutics receives FDA IND approval and secures funding of USD 34 millionLSE:0P3CKarolinska Development Ab
14/03/202410:24UK RegulatoryKarolinska Development’s portfolio company Biosergen publishes prospectus due to rights issue of unitsLSE:0P3CKarolinska Development Ab
06/03/202408:00UK RegulatoryKarolinska Development’s portfolio company Umecrine Cognition presents preclinical Parkinson’s data on golexanolone at AD/PDLSE:0P3CKarolinska Development Ab
16/02/202407:00UK RegulatoryYear-end Report - January-December 2023LSE:0P3CKarolinska Development Ab
 Showing the most relevant articles for your search:LSE:0P3C